tradingkey.logo

Nucana Says Data From Nutide:701 Shows Favorable Safety And Tumor Reduction

ReutersOct 18, 2025 12:05 PM

- NuCana PLC NCNA.O:

  • NUCANA PRESENTS ENCOURAGING DATA ON NUC-7738 IN COMBINATION WITH PD-1 INHIBITORS USING PRIMARY PATIENT-DERIVED ORGANOIDS AND AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AT THE ESMO CONGRESS 2025

  • NUCANA PLC - REGULATORS APPROVE STUDY EXPANSION FOR 28 MORE PATIENTS

  • NUCANA PLC - DATA TO DATE FROM NUTIDE:701 SHOWS FAVORABLE SAFETY AND TUMOR REDUCTION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI